• Aes Corporation (The): Jefferies downgrades to underperform from hold with a target price reduced from USD 10 to USD 9.
  • Air Lease Corporation: Citi upgrades to buy from neutral with a price target raised from USD 45 to USD 68.
  • Ati Inc.: KeyBanc Capital Markets downgrades to sector weight from overweight.
  • Blue Owl Capital Inc.: Keefe Bruyette & Woods upgrades to outperform from market perform with a price target raised from USD 20 to USD 23.
  • Celanese Corporation: BMO Capital Markets upgrades to market perform from underperform and raises the target price from USD 46 to USD 55.
  • Kinetik Holdings Inc.: Citi upgrades to buy from neutral with a price target reduced from USD 58 to USD 55.
  • Nutanix, Inc.: Raymond James downgrades to market perform from outperform.
  • Onto Innovation Inc.: Jefferies downgrades to hold from buy with a target price reduced from USD 135 to USD 110.
  • Txnm Energy, Inc.: Mizuho Securities downgrades to neutral from outperform with a price target raised from USD 56 to USD 61.25.
  • Westlake Corporation: Wells Fargo downgrades to equalweight from overweight with a target price reduced from USD 95 to USD 76.
  • Applovin Corporation: Daiwa Securities maintains its outperform recommendation and reduces the target price from 550 to USD 405.
  • Doximity, Inc.: Baird maintains its outperform recommendation and reduces the target price from USD 87 to USD 65.
  • Hewlett Packard Enterprise Company: Morgan Stanley maintains its market weight recommendation and raises the target price from 14 to USD 22.
  • Metlife, Inc.: BMO Capital Markets maintains its market perform recommendation and raises the target price from 73 to USD 90.
  • Micron Technology, Inc.: Guotai Haitong Securities maintains its overweight recommendation and reduces the target price from 162 to USD 125.
  • Netapp, Inc.: Morgan Stanley maintains its market weight recommendation and raises the target price from 84 to USD 106.
  • Pure Storage, Inc.: Morgan Stanley maintains its market weight recommendation and raises the target price from 40 to USD 62.
  • Sarepta Therapeutics, Inc.: JP Morgan maintains its overweight recommendation and reduces the target price from 169 to USD 84.
  • The Mosaic Company: BNP Paribas Exane maintains its outperform recommendation and raises the target price from USD 35 to USD 43.
  • Unitedhealth Group Inc.: Wolfe Research maintains its outperform recommendation and reduces the target price from USD 501 to USD 390.